Geode Capital Management, LLC Agenus Inc Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Agenus Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 8,099,616 shares of AGEN stock, worth $136 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,099,616

Previous 7,907,561 2.43%

Holding current value

$136 Million

Previous $6.56 Million 28.43%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.53 - $0.93 $101,789 - $178,611	192,055 Added 2.43%	8,099,616 $4.7 Million
Q4 2023 Feb 13, 2024	BUY	$0.63 - $1.14 $499,436 - $903,742	792,757 Added 11.14%	7,907,561 $6.56 Million
Q3 2023 Nov 13, 2023	BUY	$1.12 - $1.88 $699,547 - $1.17 Million	624,596 Added 9.62%	7,114,804 $8.04 Million
Q2 2023 Aug 11, 2023	BUY	$1.31 - $2.04 $1.26 Million - $1.97 Million	964,414 Added 17.45%	6,490,208 $10.4 Million
Q1 2023 May 15, 2023	BUY	$1.45 - $2.95 $400,833 - $815,489	276,437 Added 5.27%	5,525,794 $8.4 Million

Q4 2022 Feb 13, 2023	BUY	$2.02 - $3.25 $872,858 - $1.4 Million	432,108 Added 8.97%	5,249,357 $12.6 Million
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $748,880 - $1.2 Million	382,082 Added 8.61%	4,817,249 $9.88 Million
Q2 2022 Aug 12, 2022	BUY	$1.3 - $2.64 $755,755 - $1.53 Million	581,350 Added 15.09%	4,435,167 $8.6 Million
Q1 2022 May 13, 2022	SELL	$2.35 - $3.47 $577,947 - $853,394	-245,935 Reduced 6.0%	3,853,817 $9.48 Million
Q4 2021 Feb 11, 2022	BUY	$2.92 - $5.74 $1.42 Million - $2.79 Million	485,391 Added 13.43%	4,099,752 $13.2 Million
Q3 2021 Nov 12, 2021	BUY	$4.98 - $6.63 $1.14 Million - $1.51 Million	228,007 Added 6.73%	3,614,361 $19 Million
Q2 2021 Aug 13, 2021	BUY	$2.56 - $5.49 $1.49 Million - $3.2 Million	583,004 Added 20.8%	3,386,354 $18.6 Million
Q1 2021 May 12, 2021	BUY	$2.69 - $5.25 $930,080 - $1.82 Million	345,755 Added 14.07%	2,803,350 $7.63 Million
Q4 2020 Feb 12, 2021	BUY	$3.17 - $4.49 $674,629 - $955,548	212,817 Added 9.48%	2,457,595 $7.82 Million
Q3 2020 Nov 13, 2020	BUY	$2.98 - $5.2 $591,115 - $1.03 Million	198,361 Added 9.69%	2,244,778 $8.98 Million
Q2 2020 Aug 13, 2020	BUY	$2.29 - $4.24 $1.11 Million - $2.05 Million	483,798 Added 30.96%	2,046,417 $8.04 Million
Q1 2020 May 14, 2020	BUY	$1.92 - $4.39 $101,345 - $231,721	52,784 Added 3.5%	1,562,619 $3.83 Million
Q4 2019 Feb 13, 2020	BUY	$2.41 - $4.4 $286,527 - $523,120	118,891 Added 8.55%	1,509,835 $6.14 Million
Q3 2019 Nov 12, 2019	BUY	$2.17 - $3.14 $161,465 - $233,641	74,408 Added 5.65%	1,390,944 $3.59 Million
Q2 2019 Aug 14, 2019	BUY	$2.53 - $3.04 $330,240 - $396,811	130,530 Added 11.01%	1,316,536 $3.95 Million
Q1 2019 May 14, 2019	BUY	$2.51 - $3.73 $310,753 - $461,796	123,806 Added 11.66%	1,186,006 $3.52 Million
Q4 2018 Feb 13, 2019	BUY	$1.59 - $2.66 $429,125 - $717,907	269,890 Added 34.06%	1,062,200 $2.53 Million
Q3 2018 Nov 13, 2018	SELL	$1.59 - $2.42 $67,888 - $103,326	-42,697 Reduced 5.11%	792,310 $1.7 Million
Q2 2018 Aug 14, 2018	BUY	$2.26 - $4.65 $305,316 - $628,196	135,096 Added 19.3%	835,007 $1.9 Million
Q1 2018 May 15, 2018	BUY	$3.51 - $6.04 $86,370 - $148,626	24,607 Added 3.64%	699,911 $3.3 Million
Q4 2017 Feb 13, 2018	BUY	$3.26 - $4.78 $25,160 - $36,892	7,718 Added 1.16%	675,304 $2.2 Million
Q3 2017 Nov 14, 2017	BUY	$3.48 - $4.44 $190,463 - $243,005	54,731 Added 8.93%	667,586 $2.94 Million
Q2 2017 Aug 14, 2017	BUY	N/A	612,855	612,855 $2.4 Million

Others Institutions Holding AGEN

# of Institutions

128

Shares Held

205M

Call Options Held

1.18M

Put Options Held

69.8K

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.74B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Agenus Inc Transaction History